Clinical trial · Observational
Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients
Examining Sleep and Family Functioning in Pediatric Craniopharyngioma Using Ecological Momentary Assessment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Pediatric craniopharyngioma patients experience significant endocrine and sleep dysregulation difficulties. Sleep is a crucial part of children's healthy development, and sleep difficulties are associated with severe functional morbidity. Insufficient sleep, excessive daytime sleepiness, and poor sleep quality have all been significantly related to academic, behavioral, and emotional functioning in children and adolescents. Ecological momentary assessments (EMA) will be used to collect observational data. EMA data will be collected twice daily for one week. For the morning EMA administration, participants will be asked about their sleep. During the evening administration, participants will be asked about their daytime sleepiness, overall well-being, and family functioning. Covariates also administered during the evening administration include medication administration (Y/N) and total screen time. At the end of the EMA data collection period (on day 7 OR 8), participants will be sent a survey asking them to report - anonymously - their overall experience and satisfaction with the EMA data collection method.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Craniopharyngioma | Craniopharyngioma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Ecological momentary assessment (EMA)
- description
- The ecological momentary assessment (EMA) will be used for participants to complete surveys from home on two occasions each day over seven days.
Primary outcomes (1)
- measure
- Rate of participation
- timeFrame
- Once at enrollment
- description
- Study feasibility will be assessed by calculating the participation rate as follows: the number of participants who agree to participants divided by the number who are approached to participate.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 8 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Craniopharyngioma diagnosis * Access to smartphone or a tablet * Agreement to download Ilumivu application * The ability for the participant to answer questionnaires (i.e., no cognitive or developmental diagnoses that would preclude understanding and completing child self-report questionnaires) * Age between 8 and 18 years old at the time of enrollment onto St. Jude protocol RT2CR. * Participated in sleep study component of RT2CR Exclusion Criteria: * Limited English proficiency as evidenced by an inability to read and respond to EMA survey questions * Visual or sensorimotor impairment (e.g., loss of sight)
References
Publications (0)
Data not yet available